Q1 2025 Earnings Summary
Metric | YoY Change | Reason |
---|---|---|
Total Revenue | 5.2% decrease (from $118.2M to $111.997M) | Total Revenue declined likely due to lower sales volumes or pricing pressures across key markets—with the US ($65.833M), Spain ($13.616M), and Other Countries ($32.548M) all contributing to the shift from Q1 2024 to Q1 2025. |
Operating Performance | Shift from a $2,732k loss to a $780k gain | Operating performance improved as enhanced operational efficiencies and potential cost control initiatives reversed the previous period’s loss into a gain, indicating a healthier operating margin in Q1 2025 compared to Q1 2024. |
Net Loss | Narrowed from $7,761k to $1,471k | Net Loss was reduced significantly, driven by a mix of lower interest expense, reduced restructuring and cost reduction initiatives, and a notable improvement in EBITDA performance compared to the larger loss in Q1 2024. |
Basic earnings (loss) per common share | Improved from ($0.42) to ($0.09) | Basic EPS improved primarily due to the significant reduction in net loss from continuing operations, although this was partly offset by a slight increase in weighted average shares outstanding from Q1 2024 to Q1 2025. |
Cash used in operating activities | Increased by 21% (from $(11,511)k to $(13,911)k) | Operating cash flow deteriorated as working capital requirements intensified—marked by increased cash outflows from accounts payable and receivables and a decline in cash provided by income taxes—resulting in higher operating cash use in Q1 2025 versus Q1 2024. |
Total Assets | Declined from $1,205,345k to $745,782k | Total Assets dropped mainly due to the divestiture of discontinued operations, which significantly reduced the overall asset base from the previous period (Q4 2023) to Q1 2025. |
Non-current portion of debt | Dropped from $508,797k to $220,618k | Non-current debt was sharply reduced via substantial debt repayments—$290,000k paid in 2024 versus minimal new borrowing—reflecting a concerted deleveraging strategy that significantly lowered the outstanding debt compared to the previous period. |
Stockholders’ Equity | Dipped from $409,493k to $395,123k | Stockholders’ Equity decreased modestly, influenced by the net loss and equity adjustments (e.g., stock plan activity and share-based compensation expenses) in the current period relative to the previous one, indicating only a moderate contraction in overall equity. |
Metric | Period | Guidance | Actual | Performance |
---|---|---|---|---|
Net Sales | Q1 2025 | $112M – $114M | $111.997M | Missed |
Research analysts covering ZimVie.